Carter Bankshares, Inc. (CARE) Stock Forecast
CARE analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 3.50 / 5 from 4 analysts
- Price target
- $35.08 average of analyst targets
- Upside to target
- +16.1% from the latest close
- Next earnings
- October 22, 2026 EPS estimate $0.54
- 52-week range
- $16.96 – $35.72
CARE analyst ratings
4 analystsNumber of analysts at each rating.
CARE price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
CARE earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.53 | $0.50 | $0.55 | $0.26 | +103.8% | 4 |
| Current fiscal year (2026) | $5.76 | $5.45 | $6.29 | $1.39 | +314.6% | 3 |
| Next fiscal year (2027) | $2.60 | $2.50 | $2.78 | $5.76 | −54.9% | 4 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
CARE revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $45.4M | $41.7M | $47.3M | +15.6% | 3 |
| Current fiscal year (2026) | $259.5M | $248.4M | $270.5M | +69.3% | 2 |
| Next fiscal year (2027) | $204.1M | $202.0M | $206.2M | −21.3% | 2 |
CARE EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
CARE revenue: reported and forecast
CARE EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.53 | $0.53 | $0.53 | $0.52 | $0.53 | −0.6% | 2 up · 1 down |
| Current fiscal year (2026) | $5.50 | $5.46 | $5.46 | $5.50 | $5.76 | +4.9% | 2 up · 0 down |
| Next fiscal year (2027) | $2.57 | $2.57 | $2.57 | $2.58 | $2.60 | +1.3% | 2 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
CARE earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; CARE beat in 9 of 12.
What analysts expect from CARE
4 analysts cover Carter Bankshares; their consensus rating is buy (3.50 on a 1–5 scale, where 5 is a strong buy). The average price target is $35.08, 16.1% above the latest close of $30.21. Analysts expect earnings of $5.76 per share for 2026, +314.6% from a year earlier. For 2027 the average estimate is $2.60 per share on revenue of $204.1 million. Carter Bankshares beat the EPS estimate in 9 of the last 12 quarters.
Related: CARE income statement, CARE key metrics, CARE chart. See the CARE stock overview for the latest quote and news.
CARE forecast FAQ
What is Carter Bankshares's price target?
The average analyst price target for Carter Bankshares is $35.08, 16.1% above the latest close of $30.21.
Is Carter Bankshares a buy, hold or sell?
Of 4 analysts covering Carter Bankshares, 1 rate it a strong buy, 0 a buy, 3 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Carter Bankshares's EPS forecast?
Analysts forecast $5.76 per share for 2026 (range $5.45 to $6.29); for 2027 the estimate is $2.60.
What is Carter Bankshares's revenue forecast?
The average revenue estimate for 2026 is $259.5 million, growth of 69.3%; for 2027 it is $204.1 million.
When does Carter Bankshares report earnings?
Carter Bankshares is expected to report results for the quarter ending September 30, 2026 on October 22, 2026 before the market opens; the EPS estimate is $0.54.
Does Carter Bankshares usually beat earnings estimates?
Carter Bankshares reported EPS at or above the analyst estimate in 9 of the last 12 quarters.